Cot inhibitor-2,
915363-56-3,
8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]-3-Quinolinecarbonitrile,
3-Quinolinecarbonitrile, 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]-,
8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-({[1-(1-ethylpiperidin-4-yl)-1H-1,2,3-triazol-4-yl]methyl}amino)quinoline-3-carbonitrile,
8-CHLORO-4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-6-[[[1-(1-ETHYLPIPERIDIN-4-YL)-1H-1,2,3-TRIAZOL-4-YL]METHYL]AMINO]QUINOLINE-3-CARBONITRILE,
C26H25Cl2FN8,
CHEMBL527026,
SCHEMBL4962096,
BDBM29923,
CHEBI:91415,
DTXSID50657644,
PHNZIIMWDVXPGG-UHFFFAOYSA-N,
3403AH,
MFCD13184702,
ZINC42921365,
NCGC00273985-03,
NCGC00273985-04,
AN-26362,
HY-32018,
DB-015004,
FT-0759876,
W-5556,
substituted 6-aminoquinoline-3-carbonitrile, 34,
363Q563,
BRD-K49468759-001-01-8,
8-chloro-4-(3-chloro-4-fluoro-anilino)-6-[[1-(1-ethyl-4-piperidyl)triazol-4-yl]methylamino]quinoline-3-carbonitrile,
8-Chloro-4-(3-chloro-4-fluoroanilino)-6-({[1-(1-ethylpiperidin-4-yl)-1H-1,2,3-triazol-4-yl]methyl}amino)quinoline-3-carbonitrile,
8-Cl-4-[(3-Cl-4-F-phenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]-3-quinolinecarbonitrile,
CS-0033,
A3329,
A15052,